Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients

被引:58
作者
Hahn, T
Rondeau, C
Shaukat, A
Jupudy, V
Miller, A
Alam, AR
Baer, MR
Bambach, B
Bernstein, Z
Chanan-Khan, AA
Czuczman, MS
Slack, J
Wetzler, M
Mookerjee, BK
Silva, J
McCarthy, PL
机构
[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
[2] SUNY Buffalo, Sch Med & Biomed Sci, Dept Med, Buffalo, NY 14260 USA
[3] Dept Pediat Oncol, Buffalo, NY USA
[4] Roswell Pk Canc Inst, Dept Radiat Oncol, Buffalo, NY 14263 USA
关键词
renal failure; stem cell transplantations; toxicity;
D O I
10.1038/sj.bmt.1704144
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We examined the incidence, risk factors and associated mortality of acute renal failure requiring dialysis (Renal Bearman Grade [BG] 3) in a 3-year cohort of 97 consecutive allogeneic blood and marrow transplantation (alloBMT) patients. In all, 20 (21%) developed Renal BG3 (all died by day + 132) and 77 (79%) developed renal insufficiency (Renal BG1-2). Renal BG3 was a contributing or primary cause of death in 18 (90%) patients who continued to require dialysis at time of death. The two Renal BG3 patients whose deaths were not related to renal failure died on day + 103 of hemorrhage and day + 132 of underlying disease. By univariate analysis, age, unrelated donor, veno-occlusive disease (VOD) and grade III-IV acute graft-versus-host disease with hepatic involvement were significantly associated with Renal BG3. The multivariate model of time to Renal BG3 determined only a prior diagnosis of severe acute GVHD (RR = 4.1, 95% CI 1.6-10.3, P = 0.003) and VOD (RR = 9.1, 95% CI 3.5-23.7, P<0.001) as significant independent predictors. Renal BG3 is generally considered a conditioning regimen-related toxicity. This study demonstrates that Renal BG3 is most commonly a complication of hepatic co-morbidities after allogeneic blood and marrow transplantation and identifies patients with a very poor prognosis.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 26 条
[11]   ACUTE-RENAL-FAILURE IN PATIENTS FOLLOWING BONE-MARROW TRANSPLANTATION - PREVALENCE, RISK-FACTORS AND OUTCOME [J].
GRUSS, E ;
BERNIS, C ;
TOMAS, JF ;
GARCIACANTON, C ;
FIGUERA, A ;
MOTELLON, JL ;
PARAISO, V ;
TRAVER, JA ;
FERNANDEZRANADA, JM .
AMERICAN JOURNAL OF NEPHROLOGY, 1995, 15 (06) :473-479
[12]  
GUINAN EC, 1988, BLOOD, V72, P451
[13]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[14]   ACUTE RENAL TOXICITY WITH COMBINED USE OF AMPHOTERICIN-B AND CYCLOSPORINE AFTER MARROW TRANSPLANTATION [J].
KENNEDY, MS ;
DEEG, HJ ;
SIEGEL, M ;
CROWLEY, JJ ;
STORB, R ;
THOMAS, ED .
TRANSPLANTATION, 1983, 35 (03) :211-215
[15]   Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation [J].
Lawton, CA ;
Cohen, EP ;
Murray, KJ ;
Derus, SW ;
Casper, JT ;
Drobyski, WR ;
Horowitz, MM ;
Moulder, JE .
BONE MARROW TRANSPLANTATION, 1997, 20 (12) :1069-1074
[16]   VENO-OCCLUSIVE DISEASE OF THE LIVER AFTER BONE-MARROW TRANSPLANTATION - DIAGNOSIS, INCIDENCE, AND PREDISPOSING FACTORS [J].
MCDONALD, GB ;
SHARMA, P ;
MATTHEWS, DE ;
SHULMAN, HM ;
THOMAS, ED .
HEPATOLOGY, 1984, 4 (01) :116-122
[17]   Renal toxicity after allogeneic bone marrow transplantation: The combined effects of total-body irradiation and graft-versus-host disease [J].
Miralbell, R ;
Bieri, S ;
Mermillod, B ;
Helg, C ;
Sancho, G ;
Pastoors, B ;
Keller, A ;
Kurtz, JM ;
Chapuis, B .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :579-585
[18]   Thrombotic microangiopathies associated with drugs and bone marrow transplantation [J].
Moake, JL ;
Byrnes, JJ .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (02) :485-&
[19]  
NASH RA, 1992, BLOOD, V80, P1838
[20]   Renal failure and bone marrow transplantation [J].
Noel, C ;
Hazzan, M ;
Noel-Walter, MP ;
Jouet, JP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (10) :2464-2466